The NDoH has confirmed the resumption date of the Sisonke Vaccination Programme, following a temporary halt in the rollout due to new revelations on the Johnson & Johnson vaccine.
The National Department of Health (NDoH) took to Twitter on Monday, 26 April 2021, to confirm that it is set to resume with the Sisonke Vaccination Programme. The programme was halted earlier this month, in light of the Food and Drug Association’s (FDA) findings that the Johnson & Johnson vaccine could cause severe blood clots.
This led to the NDoH halting the vaccination programme as a way to ensure the safety of citizens. It is believed that because the findings were of a small portion of those who have been vaccinated, the department has decided to forge ahead with the vaccination programme.
The Sisonke Vaccination Programme is set to resume on Wednesday, 28 April 2021, with a continued focus on healthcare workers. Moreover, the department has remained steadfast in commencing with phase two on Monday, 17 May 2021.
See the post below.
Today we are pleased to announce that, following SAHPRA’s recommendation on 17 April 2021 and Cabinet’s concurrence on 21 April 2021, the vaccine rollout will re- sume through the Sisonke Programme on Wednesday, 28 April 2021 #vaccine #VaccineRolloutSA pic.twitter.com/wOrZ68THaz
— Department of Health (@HealthZA) April 26, 2021